Q: What is Tysabri?
A: Tysabri is a drug used to treat both multiple sclerosis (MS) and Crohn’s disease. It is jointly marketed by Elan, an Irish drugmaker, and Biogen Idec, an American biotechnology firm. It is administered through IV infusion every few weeks, and has shown some promise in treating MS.